Embracing Biosimilars in IBD: How Can We Leverage Them in Our Practice?
![]()
UPCOMING | TBA
Expert Illustrations & Commentaries Live!™: Antithrombotic Approaches to Reduce the Risk of Secondary Events in CAD and PAD
![]()
UPCOMING | TBA
8th Annual School of Gastrointestinal Oncology® (SOGO®)
![]()
UPCOMING | TBA